BiotechTube
Home/NovaLead Pharma/Supreet Deshpande
SD

Supreet Deshpande

Managing Director, Founder

NovaLead Pharma

Therapeutic Areas

Diabetic Foot UlcerPsoriasisChronic WoundsInflammatory Skin Diseases

NovaLead Pharma Pipeline

DrugIndicationPhase
Galnobax®Diabetic Foot Ulcer (DFU)Phase 3
NLP91Psoriasis / Inflammatory Skin DiseasesPre-clinical

Leadership Team at NovaLead Pharma

AA
Atul Aslekar
Chief Technology Officer, Co-founder
DS
Dr. Sudhir Kulkarni
Vice President, Discovery
YG
Yogini Garud
Vice President, Finance
KJ
Kamalakar Jadhav
Vice President, Technology
View full NovaLead Pharma profile